Lonza Group Ltd
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma&Biotech and Specialty Ingredients. Its products and services cover bio research solutions, such as stem cells primary cells and media, cell culture, transfection, exosomes, and assay solutions; electrophoresis of nucleic acids and proteins; primary and stem cell protocols; Hepatocytes/ADMETox solutions for microsomes and primary cell culture applications; and CytoSMART system, a live cell imaging and monitoring system. The company's products and services also cover pharma and biotech solutions, such as bioprocess systems, drug discovery, endotoxin detection, informatics, bioassay services, and encapsulation technologies; consumer health solutions comprising hygiene, nutrition, personal care, preservation, and capsules and food supplements; and agro ingredients, such as intermediates, molluscicides, specialties, formulation ingredients, crop protection, and animal care solutions. In addition, its products and services include coatings and composites, performance intermediates, composite materials, and functional chemicals; and materials protection, oil and gas, marine antifouling, hydrazine, and wood protection solutions. The company serves pharmaceutical, biotech, consumer health, nutrition, and specialty chemicals and industrial markets. Lonza Group Ltd has a strategic collaboration agreement with Prevail Therapeutics Inc. to develop and manufacture Prevail's AAV9 gene therapy programs for patients with neurodegenerative diseases; and a collaboration with Triumvira Immunologics, Inc. for the development of Triumvira's TAC01-HER2 T-cell therapy for treating solid tumors. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland. Show More...
-
Website http://www.lonza.com
-
Sector Healthcare
-
Industry Diagnostics & Research
-
Last Quote 569.20 CHF
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CHF 5.12 2.75 3.1 1.55 4.21 4.87 5.28 10.33 7.48 8.65 8.65 Dividends CHF 1.62 1.99 1.99 1.99 1.99 2.32 2.32 2.75 2.75 2.75 Payout Ratio % * 51.9 44.7 74.4 80.5 60.4 63.0 36.6 22.3 31.1 26.9 Shares Mil 57.0 56.0 56.0 56.0 56.0 57.0 57.0 68.0 75.0 75.0 75.0 Book Value Per Share * CHF 41.96 38.51 38.89 35.43 34.28 32.15 33.35 71.54 85.62 83.11 87.42 Free Cash Flow Per Share * CHF 0.25 3.35 3.0 3.51 6.89 8.35 8.52 4.37 5.52 1.58 Return on Assets % 5.99 2.61 2.58 1.28 3.65 4.37 4.6 7.04 4.03 4.65 4.65 Financial Leverage (Average) 2.0 2.98 2.95 3.08 3.02 2.93 2.9 2.22 2.24 2.13 2.13 Return on Equity % 12.35 6.49 7.64 3.84 11.14 12.99 13.41 16.96 9.0 10.15 10.15 Return on Invested Capital % 8.56 4.78 4.97 3.49 6.56 8.04 8.71 10.57 6.16 6.9 6.9 Interest Coverage 7.73 2.92 3.17 1.97 4.67 5.26 5.91 8.75 9.23 10.43 10.43 Current Ratio 1.31 1.99 1.51 1.57 1.21 1.17 1.27 1.26 1.48 1.14 1.14 Quick Ratio 0.82 1.13 0.92 0.89 0.61 0.58 0.62 0.67 0.58 0.59 0.59 Debt/Equity 0.38 1.17 1.01 1.06 0.79 0.66 0.67 0.6 0.58 0.46 0.46